Rezolute RZLT
NASDAQ RZLT
$4.58 +0.04 (+0.88%)
As of: Sep 4, 2026 · 3:59 PM EDT

Rezolute (RZLT) Accounts Payables (2011 - 2026)

Rezolute (RZLT) posted Accounts Payables of $3.2 million for Q1 2026, down 15.54% sequentially from $3.8 million in Q4 2025, and down 50.86% YoY from $6.5 million in Q1 2025.

Analysis

Rezolute (RZLT) Accounts Payables (2011 - 2026) Analysis & Trends

Rezolute has reported Accounts Payables for 16 years, with the latest figure at $3.2 million in Q1 2026.

  • Quarterly Accounts Payables fell 50.86% year-over-year to $3.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.2 million (down 50.86% YoY) and the FY2025 annual result came in at $5.8 million, up 18.53% from the prior year.
  • Accounts Payables retreated to $3.2 million in Q1 2026 per RZLT's latest filing, from $3.8 million in the prior quarter.
  • Over five years, Accounts Payables peaked at $6.5 million in Q1 2025 and troughed at $1.1 million in Q3 2022.
  • A 5-year average of $3.2 million and a median of $3.2 million in 2026 frame the typical range for Accounts Payables.
  • The sharpest annual moves came in 2023 and 2026: Accounts Payables soared 188.78% in 2023, then tumbled 50.86% in 2026.
  • Over 5 years, Accounts Payables stood at $2.8 million in 2022, then advanced by 26.47% to $3.6 million in 2023, then fell by 12.36% to $3.1 million in 2024, then gained by 20.13% to $3.8 million in 2025, then declined by 15.54% to $3.2 million in 2026.
  • According to Business Quant data, Accounts Payables over the past three periods registered $3.2 million, $3.8 million, and $3.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Accounts Payables (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 429.50 Mn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 1.16 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn 1.52 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 167.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn - 88.42 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 470.30 Mn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 108.02 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn - 35.57 Mn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 428.93 Mn
10 Rezolute 477.02 Mn 477.02 Mn - 3.20 Mn
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 3.20 Mn
Dec 31, 2025 3.78 Mn
Sep 30, 2025 3.26 Mn
Jun 30, 2025 5.81 Mn
Mar 31, 2025 6.50 Mn
Dec 31, 2024 3.15 Mn
Sep 30, 2024 2.18 Mn
Jun 30, 2024 4.90 Mn
Mar 31, 2024 3.50 Mn
Dec 31, 2023 3.59 Mn
Sep 30, 2023 2.43 Mn
Jun 30, 2023 3.27 Mn
Mar 31, 2023 2.95 Mn
Dec 31, 2022 2.84 Mn
Sep 30, 2022 1.11 Mn
Jun 30, 2022 1.13 Mn
Mar 31, 2022 1.56 Mn
Dec 31, 2021 4.35 Mn
Sep 30, 2021 1.59 Mn
Jun 30, 2021 1.04 Mn